Moderna (MRNA) fell 7.0% on 12 Nov 2026. The stock closed at $231.35, against $248.69 the session before.
That puts the company's market value at about $93.6B. The 52-week range is $22.28 to $280.80, so the stock now sits 17.6% below the top of it.
Over the past 52 weeks the shares have moved +896.4%.
Figures from Yahoo Finance at the time of writing. Not investment advice.